MQS Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$844K Buy
9,736
+2,880
+42% +$276K 0.57% 18
2025
Q4
$659K Buy
+6,856
New +$666K 0.39% 69
2025
Q2
Sell
-7,715
Closed -$693K 581
2025
Q1
$693K Buy
+7,715
New +$690K 0.4% 54
2024
Q3
Sell
-9,363
Closed -$737K 569
2024
Q2
$737K Buy
9,363
+3,587
+62% +$294K 0.45% 36
2024
Q1
$503K Buy
+5,776
New +$493K 0.29% 118
2022
Q4
Sell
-8,305
Closed -$671K 503
2022
Q3
$671K Buy
+8,305
New +$746K 0.43% 49
2022
Q1
Sell
-4,404
Closed -$456K 388
2021
Q4
$456K Buy
+4,404
New +$510K 0.73% 34

Other funds holding MDT

MQS Management's MDT Position: Q1 2026 in Review

MQS Management increased its Medtronic (MDT) stake by 42% in Q1 2026, buying an estimated $276K and bringing the position to 9,736 shares worth $844K. The position accounts for 0.57% of the portfolio, ranked #18.

MQS Management first reported a position in MDT in Q4 2021 and has held it in 7 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • MQS Management held 9,736 shares of Medtronic worth $844K as of Q1 2026.
  • MQS Management bought 2,880 Medtronic shares in Q1 2026, an estimated $276K.
  • Medtronic made up 0.57% of MQS Management's portfolio in Q1 2026, its #18 holding.
  • MQS Management first reported a position in Medtronic in Q4 2021 and has held it in 7 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on MQS Management's 13F filing for Q1 2026, filed 23 Apr 2026.